Alopecia associated with gabapentin in the treatment of neuropathic pain.
Eker
H Evren
HE
Cok
Oya Yalcin
OY
Aribogan
Anis
A
D000505:Alopecia / Q000139:chemically induced*; D000588:Amines / Q000009:adverse effects* / Q000627:therapeutic use; D018712:Analgesics, Non-Narcotic / Q000009:adverse effects* / Q000627:therapeutic use; D003509:Cyclohexanecarboxylic Acids / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D000077206:Gabapentin; D006197:Hair / Q000254:growth & development; D006801:Humans; D008875:Middle Aged; D010523:Peripheral Nervous System Diseases / Q000188:drug therapy* / Q000209:etiology*; D000070599:Shoulder Injuries; D020069:Shoulder Pain / Q000150:complications* / Q000188:drug therapy* / Q000209:etiology; D005680:gamma-Aminobutyric Acid / Q000009:adverse effects* / Q000627:therapeutic use
D000588:Amines; D018712:Analgesics, Non-Narcotic; D003509:Cyclohexanecarboxylic Acids; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin